Meeting
2021 Gastrointestinal Cancers Symposium
The use of elevated circulating hepatocyte growth factor (HGF) level as a potential prognostic biomarker in locally advanced pancreatic cancer.
Authors
Hannah Johnson Roberts
Massachusetts General Hospital, Boston, MA
Hannah Johnson Roberts , Jennifer Yon-Li Wo , Beow Y. Yeap , Christine A. Ulysse , Janet E. Murphy , Colin D. Weekes , David P. Ryan , Jeffrey William Clark , Cristina R. Ferrone , Keith D. Lillemoe , Motaz Qadan , Carlos Fernandez-del Castillo , Rakesh K. Jain , Theodore S. Hong , Gabriel Dan Duda
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Pancreatic Cancer
Track
Pancreatic Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 429)
DOI
10.1200/JCO.2021.39.3_suppl.429
Abstract #
429
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
New cutoff of CA19-9 values for predicting pancreatic cancer using liquid biopsy.
First Author: Ryuji Hasebe
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of race and CA 19-9 nonproduction with limited pathologic response to neoadjuvant chemotherapy in patients with localized pancreatic cancer.
First Author: Mary P. Martos
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Lymphopenia and spleen dose for patients with inoperable pancreatic cancer receiving ablative 5-fraction radiation therapy.
First Author: Michael David Chuong
Poster
2024 ASCO Gastrointestinal Cancers Symposium
KRAS mutation status in the prediction of pancreatic tumor response after neoadjuvant systemic therapy and magnetic resonance-guided SBRT.
First Author: Amit Jethanandani